Trupanion, Inc. $TRUP Shares Bought by Hosking Partners LLP

Hosking Partners LLP boosted its stake in shares of Trupanion, Inc. (NASDAQ:TRUP) by 8.1% in the fourth quarter, HoldingsChannel.com reports. The fund owned 465,950 shares of the financial services provider’s stock after purchasing an additional 35,020 shares during the period. Hosking Partners LLP’s holdings in Trupanion were worth $17,413,000 at the end of the most recent reporting period.

A number of other large investors also recently added to or reduced their stakes in the stock. R Squared Ltd raised its position in Trupanion by 44.7% during the fourth quarter. R Squared Ltd now owns 9,075 shares of the financial services provider’s stock worth $339,000 after acquiring an additional 2,803 shares during the period. Kopion Asset Management LLC raised its holdings in shares of Trupanion by 11.0% during the fourth quarter. Kopion Asset Management LLC now owns 293,706 shares of the financial services provider’s stock valued at $10,976,000 after acquiring an additional 29,103 shares during the last quarter. Tudor Investment Corp ET AL lifted its position in shares of Trupanion by 183.7% in the third quarter. Tudor Investment Corp ET AL now owns 237,125 shares of the financial services provider’s stock valued at $10,263,000 after acquiring an additional 153,530 shares in the last quarter. CIBC Bancorp USA Inc. purchased a new position in shares of Trupanion in the third quarter valued at approximately $367,000. Finally, Advisory Services Network LLC purchased a new position in shares of Trupanion in the third quarter valued at approximately $160,000.

Insider Buying and Selling

In related news, COO John R. Gallagher sold 5,283 shares of Trupanion stock in a transaction that occurred on Friday, February 27th. The stock was sold at an average price of $26.52, for a total transaction of $140,105.16. Following the transaction, the chief operating officer owned 32,387 shares in the company, valued at approximately $858,903.24. This trade represents a 14.02% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, CRO Emily Dreyer sold 7,792 shares of the firm’s stock in a transaction dated Wednesday, March 4th. The stock was sold at an average price of $28.15, for a total transaction of $219,344.80. Following the sale, the executive owned 35,627 shares of the company’s stock, valued at approximately $1,002,900.05. The trade was a 17.95% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Over the last 90 days, insiders have sold 21,503 shares of company stock worth $578,537. 5.42% of the stock is owned by corporate insiders.

Analyst Ratings Changes

Several research firms have recently weighed in on TRUP. Zacks Research downgraded Trupanion from a “strong-buy” rating to a “hold” rating in a research report on Friday, February 13th. Cantor Fitzgerald decreased their target price on Trupanion from $42.00 to $34.00 and set a “neutral” rating on the stock in a research report on Thursday, April 9th. Bank of America decreased their target price on Trupanion from $63.00 to $59.00 and set a “buy” rating on the stock in a research report on Tuesday, April 14th. Stifel Nicolaus decreased their target price on Trupanion from $35.00 to $31.00 and set a “hold” rating on the stock in a research report on Tuesday, March 31st. Finally, Weiss Ratings cut shares of Trupanion from a “hold (c-)” rating to a “sell (d+)” rating in a research report on Wednesday, March 4th. Two research analysts have rated the stock with a Buy rating, three have assigned a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat.com, Trupanion has a consensus rating of “Hold” and a consensus target price of $42.25.

Trupanion Stock Performance

NASDAQ:TRUP opened at $24.61 on Monday. The company’s 50-day moving average price is $26.20 and its 200-day moving average price is $32.46. The company has a current ratio of 1.73, a quick ratio of 1.73 and a debt-to-equity ratio of 0.25. The company has a market cap of $1.07 billion, a P/E ratio of 41.71 and a beta of 1.49. Trupanion, Inc. has a twelve month low of $23.80 and a twelve month high of $57.88.

Trupanion (NASDAQ:TRUP) last announced its quarterly earnings data on Thursday, April 30th. The financial services provider reported $0.11 EPS for the quarter, topping analysts’ consensus estimates of $0.07 by $0.04. Trupanion had a return on equity of 6.87% and a net margin of 1.74%.The firm had revenue of $384.05 million for the quarter, compared to the consensus estimate of $379.77 million. During the same quarter last year, the business posted ($0.03) earnings per share. The firm’s revenue was up 12.3% compared to the same quarter last year. On average, sell-side analysts forecast that Trupanion, Inc. will post 0.53 earnings per share for the current fiscal year.

Trupanion Profile

Trupanion, Inc is a pet medical insurance company that provides comprehensive insurance coverage for cats and dogs. The company’s core offering is a single, customizable medical policy designed to cover veterinary diagnostic tests, surgeries, hospital stays and congenital or hereditary conditions. Trupanion seeks to streamline the claims process by offering direct payment options to participating veterinarians, reducing the need for upfront payments by pet owners.

Founded in 1999 by Darryl Rawlings and headquartered in Seattle, Washington, Trupanion began operations in the early 2000s and has grown its presence through both digital channels and partnerships with veterinary hospitals.